Stocks
Edwards Lifesciences (EW) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | -0.41 | -0.52 | -0.29 | -0.29 | -0.49 | -0.59 | |||
| Changes by years, y/y, % | -35% | +28% | -44% | -3% | +70% | +13.3% | |||
Edwards Lifesciences. Debt/EBITDA
Edwards Lifesciences. Debt/EBITDA, changes, %
Edwards Lifesciences (EW) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | 2024Q1 | LTM ? | |||
| Debt/EBITDA | -0.61 | -0.51 | -0.52 | -0.57 | -0.53 | -0.59 | ||
| Changes by years, y/y, % | +4% | +77% | +81% | +88% | +74% | |||
| Changes by quarters, q/q, % | 0% | -17% | +2% | +11% | -7% | |||
